BATEMAN'S PURPURA
Showing 1 - 25 of 218
Senile Purpura, Bateman's Purpura Trial in Boynton Beach (Broad Band Light (BBL))
Completed
- Senile Purpura
- Bateman's Purpura
- Broad Band Light (BBL)
-
Boynton Beach, FloridaSiperstein Dermatology Group
Apr 10, 2021
Association Between Dermatoporosis and Fractural Risk
Completed
- Dermatoporosis
- Dual X-ray absorptiometry (DMO) densitometry.
-
Paris, FranceHôpital Fondation Adolphe de Rothschild
Jul 16, 2021
Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura
Not yet recruiting
- ITP - Immune Thrombocytopenia
- eltrombopag and romiplastim
- (no location specified)
Nov 16, 2023
Henoch-Schonlein Purpura Trial in Guangzhou (Leflunomide)
Recruiting
- Henoch-Schonlein Purpura
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 1, 2023
Rheumatoid Purpura in Children:Multicenter Observational Study
Not yet recruiting
- Rheumatoid Purpura
- Management of rheumatoid purpura
- (no location specified)
Feb 10, 2023
Purpura, Thrombocytopenic Trial in Sevilla (Standard clinical practice)
Not yet recruiting
- Purpura, Thrombocytopenic
- Standard clinical practice
-
Sevilla, Andalucia, SpainHospital Universitario Virgen del Rocío
Jun 13, 2023
Idiopathic Thrombocytopenic Purpura Trial (Placebo, AMG 531)
Completed
- Idiopathic Thrombocytopenic Purpura
- Placebo
- AMG 531
- (no location specified)
Nov 4, 2022
COVID-19 Vaccine and Development of Immune Thrombocytopenic
Recruiting
- COVID-19 Vaccine
- covid19 vaccines
-
Assiut, EgyptEgypt
Jul 12, 2022
Henoch-Schönlein Purpura, Gastrointestinal Injury, Mycophenolate Mofetil Trial in Guangzhou (MMF)
Recruiting
- Henoch-Schönlein Purpura
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 18, 2023
Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069)
Enrolling by invitation
- Idiopathic Thrombocytopenic Purpura
- GNR-069
-
Irkutsk, Irkutsk Region, Russian Federation
- +12 more
Aug 5, 2022
Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069, Nplate)
Recruiting
- Idiopathic Thrombocytopenic Purpura
- GNR-069
- Nplate
-
Irkutsk, Irkutsk Region, Russian Federation
- +17 more
Aug 3, 2022
Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)
No longer available
- Thrombotic Thrombocytopenic Purpura (TTP)
- (no location specified)
Mar 3, 2023
TTP - Thrombotic Thrombocytopenic Purpura Trial in Ankara
Recruiting
- TTP - Thrombotic Thrombocytopenic Purpura
-
Ankara, TurkeyBaskent Universtiy Faculty of Medicine
Jul 15, 2023
Pediatric Primary Immune Thrombocytopenia (ITP)
Recruiting
- Primary Immune Thrombocytopenia
- data collection
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023
Caplacizumab in Treatment of Acquired Thrombotic
Not yet recruiting
- Acquired Thrombotic Thrombocytopenic Purpura
-
Cologne, GermanyUniversity Hospital of Cologne
May 25, 2023
Acquired Thrombotic Thrombocytopenic Purpura Trial in Worldwide (Caplacizumab, Standard of Care)
Completed
- Acquired Thrombotic Thrombocytopenic Purpura
- Caplacizumab
- Standard of Care
-
Saint Louis, Missouri
- +44 more
Mar 21, 2022
.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)
Recruiting
- Thrombotic Thrombocytopenic Purpura
-
Mainz, GermanyUniversity Hospital Mainz, Hematology
May 20, 2022
Idiopathic Thrombocytopenic Purpura Trial in Multiple Locations (R788, Placebo)
Active, not recruiting
- Idiopathic Thrombocytopenic Purpura
- R788
- Placebo
-
Multiple Locations, JapanResearch Site
Mar 22, 2022
Immune Thrombocytopenia Trial (VIT D)
Not yet recruiting
- Immune Thrombocytopenia
- VIT D
- (no location specified)
Oct 5, 2023
Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura (TTP)
- TAK-755
- (no location specified)
Feb 9, 2023
Construction of a Database for TTP
Recruiting
- TTP - Thrombotic Thrombocytopenic Purpura
- collection data
-
Suzhou, Jiangsu, Chinathe first affiliated hospital of Soochow university
Oct 5, 2022
Thrombotic Thrombocytopenic Purpura Trial in Japan (Caplacizumab (ALX-0081), Plasma exchange (PE), Corticosteroid treatment
Completed
- Thrombotic Thrombocytopenic Purpura
- Caplacizumab (ALX-0081)
- +3 more
-
Iruma-Gun, Japan
- +11 more
Jan 30, 2023
Immune Thrombocytopenic Purpura Trial in Sohag (serum interleukin 10 level)
Not yet recruiting
- Immune Thrombocytopenic Purpura
- serum interleukin 10 level
-
Sohag, EgyptSohag University Hospital
Apr 18, 2023